Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449].

Dancey, C P; Attree, E A; Brown, K F

Dancey, C P; Attree, E A; Brown, K F.

Affiliation

Dancey CP; University of East London, UK. C.P.Dancey@uel.ac.uk

Nutr J ; 5: 16, 2006 Jun 08.

Article in En | MEDLINE | ID: mdl-16762076

Subject(s)

Irritable Bowel Syndrome/drug therapy; Nucleotides/administration & dosage; Abdominal Pain; Adolescent; Adult; Aged; Constipation; Diarrhea; Dietary Supplements; Double-Blind Method; Female; Flatulence; Humans; Irritable Bowel Syndrome/physiopathology; Irritable Bowel Syndrome/psychology; Male; Middle Aged; Placebos; Saccharomyces cerevisiae/chemistry; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Irritable Bowel Syndrome / Nucleotides Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Nutr J Journal subject: CIENCIAS DA NUTRICAO Year: 2006 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google